Study familial hypertrophic cardiomyopathy using patient-specific induced pluripotent stem cells
about
G-protein Coupled Receptor Signaling in Pluripotent Stem Cell-derived Cardiovascular Cells: Implications for Disease ModelingCardiovascular Disease Modeling Using Patient-Specific Induced Pluripotent Stem CellsMutation-Specific Phenotypes in hiPSC-Derived Cardiomyocytes Carrying Either Myosin-Binding Protein C Or α-Tropomyosin Mutation for Hypertrophic Cardiomyopathy.Cardiac Troponin and Tropomyosin: Structural and Cellular Perspectives to Unveil the Hypertrophic Cardiomyopathy PhenotypePatient Specific Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Drug Development and Screening In Catecholaminergic Polymorphic Ventricular TachycardiaRecent Advances in the Molecular Genetics of Familial Hypertrophic Cardiomyopathy in South Asian DescendantsModelling sarcomeric cardiomyopathies in the dish: from human heart samples to iPSC cardiomyocytesIdentification and Functional Characterization of a Novel CACNA1C-Mediated Cardiac Disorder Characterized by Prolonged QT Intervals With Hypertrophic Cardiomyopathy, Congenital Heart Defects, and Sudden Cardiac Death.Mimicking Cardiac Fibrosis in a Dish: Fibroblast Density Rather than Collagen Density Weakens Cardiomyocyte FunctionMechanism of automaticity in cardiomyocytes derived from human induced pluripotent stem cells.Modeling and study of the mechanism of dilated cardiomyopathy using induced pluripotent stem cells derived from individuals with Duchenne muscular dystrophy.Novel Analysis Software for Detecting and Classifying Ca2+ Transient Abnormalities in Stem Cell-Derived Cardiomyocytes.Liensinine- and Neferine-Induced Cardiotoxicity in Primary Neonatal Rat Cardiomyocytes and Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes.Generation of electrophysiologically functional cardiomyocytes from mouse induced pluripotent stem cellsBiology of the cardiac myocyte in heart disease.Cardiomyocytes from human pluripotent stem cells: From laboratory curiosity to industrial biomedical platform.Interleukin-18 deteriorates Fabry cardiomyopathy and contributes to the development of left ventricular hypertrophy in Fabry patients with GLA IVS4+919 G>A mutationPatient-Specific Induced Pluripotent Stem Cell Models: Generation and Characterization of Cardiac CellsNew approaches to establish genetic causality.Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes as a Model for Heart Development and Congenital Heart Disease.Differential Sarcomere and Electrophysiological Maturation of Human iPSC-Derived Cardiac Myocytes in Monolayer vs. Aggregation-Based Differentiation Protocols.Untangling the Biology of Genetic Cardiomyopathies with Pluripotent Stem Cell Disease Models.Danshen-Enhanced Cardioprotective Effect of Cardioplegia on Ischemia Reperfusion Injury in a Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes Model.Induced pluripotent stem cells: at the heart of cardiovascular precision medicine.Contractile Defect Caused by Mutation in MYBPC3 Revealed under Conditions Optimized for Human PSC-Cardiomyocyte FunctionHuman Induced Pluripotent Stem Cells as a Platform for Personalized and Precision Cardiovascular Medicine.Disease modelling using human iPSCs.Can Human Pluripotent Stem Cell-Derived Cardiomyocytes Advance Understanding of Muscular Dystrophies?Molecular Approaches in HFpEF: MicroRNAs and iPSC-Derived Cardiomyocytes.Stem Cells in Cardiovascular Medicine: the Road to Regenerative Therapies.Human heart disease: lessons from human pluripotent stem cell-derived cardiomyocytes.Human pluripotent stem cell models of cardiac disease: from mechanisms to therapies.Deficient cMyBP-C protein expression during cardiomyocyte differentiation underlies human hypertrophic cardiomyopathy cellular phenotypes in disease specific human ES cell derived cardiomyocytes.Divergent effect of adrenaline in human induced pluripotent stem cell derived cardiomyocytes obtained from hypertrophic cardiomyopathy.Investigating the cardiac pathology of SCO2-mediated hypertrophic cardiomyopathy using patients induced pluripotent stem cell-derived cardiomyocytes.The Impact of CRISPR/Cas9 Technology on Cardiac Research: From Disease Modelling to Therapeutic Approaches.Mitochondrial Dysfunctions Contribute to Hypertrophic Cardiomyopathy in Patient iPSC-Derived Cardiomyocytes with MT-RNR2 Mutation.Hypertrophic cardiomyopathy-linked mutation in troponin T causes myofibrillar disarray and pro-arrhythmic action potential changes in human iPSC cardiomyocytes.Structural Immaturity of Human iPSC-Derived Cardiomyocytes: In Silico Investigation of Effects on Function and Disease Modeling.Reconciling computer models and stem cell models of human cardiac repolarization: reply.
P2860
Q26772221-EEDDB96E-DC48-47C3-B335-F987BFAE822EQ26798131-EDC1B827-27CA-433F-9CD8-2A9C17100661Q27314792-606D025F-B158-4D9A-8165-EEBA73DCAB70Q28066435-2850D623-8978-4EB1-AA5E-B3A52C3E5169Q28067569-F035D076-D989-421E-90BE-8EB3EDD7CCC4Q28075331-444E3956-826B-4472-8FF7-6581A260F18EQ28255887-A7E6DEB4-DBFA-41B8-9359-B21BE81B082EQ29347533-BDEEDC60-3C00-40F9-B6A2-0DAEC5EABB93Q33705089-7ADC8BBE-C3C5-4C15-8244-04DFF674C354Q35538120-909D512F-3EC1-43A1-93D0-541E923599ABQ35558056-8F31E5F4-A9D8-443E-9A66-31D05DAD63B2Q35755909-964F13E3-84AA-41D2-AEE6-4A0FFAE54301Q36667033-03D17245-7A51-4413-AA08-45C797C5B616Q36788817-5CEE7728-4898-4984-A1EB-D73722651D13Q37095254-A8AC2081-15DB-4AF7-9831-80AC75B6B672Q37573646-FCEA4421-2EDE-49AB-88AD-0502CD8F4AADQ37699393-36DE3E19-6ED6-46D3-9169-DBF0DD9E8980Q37710335-303D023F-0C10-483A-B68E-01E66C2E9AA9Q38416344-01B2A803-D6D1-413E-B9A2-CB3487C1E9D8Q38530607-75F0CCBF-0AD5-49C9-8CD6-05E293B163E0Q38740489-7170EEE4-3901-435D-9D29-E162280D2E7EQ38743378-932754AA-21B9-4ED4-9A03-FF4FC0ECFCA0Q38786228-4AF0D9EB-DD1D-4375-866F-3686A9B935ABQ38786687-1E832532-F95B-4E57-BD0E-29FD1AEC213BQ38826141-C9B28E84-EF09-461C-B2B3-968863DA4376Q38874111-341D9F3C-F729-43FC-A946-078E1AA79119Q38919220-C484BF87-D707-47B3-B186-D5563B7850BCQ39010745-0FE92B49-09AA-46BB-9BFB-747F3E4C225BQ39061922-85EEB6AD-88AA-4006-9210-42DE4E78A66EQ39190689-5A83502B-F19F-4641-B1EA-6F11F7A8E1A7Q39345477-FD211C3C-4059-4D2D-8AB2-E3C386812399Q41664792-FBFB2090-228E-42E2-B425-989CAE950244Q41700317-655811CC-CB10-49E0-AA29-1F4900871B8DQ48183741-4C083A55-AA48-4FA6-A253-8197036CF9B4Q48199735-F132F837-7AAC-488C-B991-FF52525A635CQ49432567-04AD213C-DA82-4F90-B974-A2A703E3B04DQ49886497-CE356DA4-C9BF-4958-AFA4-6C40EBFED35FQ50022359-1E64B6CD-F71A-4C1A-BCA0-55C1AA1A5FDAQ50219235-B0BF7315-D005-4C32-A7AE-12E19CF20AC1Q50600414-64FCDF69-19D1-48E9-938D-96A71D920192
P2860
Study familial hypertrophic cardiomyopathy using patient-specific induced pluripotent stem cells
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Study familial hypertrophic ca ...... induced pluripotent stem cells
@ast
Study familial hypertrophic ca ...... induced pluripotent stem cells
@en
Study familial hypertrophic ca ...... induced pluripotent stem cells
@nl
type
label
Study familial hypertrophic ca ...... induced pluripotent stem cells
@ast
Study familial hypertrophic ca ...... induced pluripotent stem cells
@en
Study familial hypertrophic ca ...... induced pluripotent stem cells
@nl
prefLabel
Study familial hypertrophic ca ...... induced pluripotent stem cells
@ast
Study familial hypertrophic ca ...... induced pluripotent stem cells
@en
Study familial hypertrophic ca ...... induced pluripotent stem cells
@nl
P2093
P2860
P50
P3181
P356
P1476
Study familial hypertrophic ca ...... induced pluripotent stem cells
@en
P2093
Aaron D Kaplan
Agnieszka Lis
Jason Tchao
Jocelyn Mich-Basso
Narmeen Hassan
Randall L Rasmusson
P2860
P304
P3181
P356
10.1093/CVR/CVU205
P407
P577
2014-09-10T00:00:00Z